Your Article Summary
See Latest ArticlesSmall cell cancer of the bladder: pathology, diagnosis, treatment and prognosis
Bulletin du Cancer, 06/29/09
Ismaili N et al. - The most common staging system used is the two-stage system (limited-extensive). Because of the rarity of the disease, the management is extrapolated from that of SCLC. Limited-stage disease should be treated with etoposide-cisplatin chemotherapy in combination either with radiotherapy, or surgery or both. Extensive-stage disease should be managed by combined chemotherapy.
Related Articles
Incidence analyses of bladder cancer in the Nile delta region of Egypt
Cancer Epidemiology, 10/20/09
Relevance Score: 84%
Survivin as a prognostic marker for urothelial carcinoma of the bladder: A multicenter external validation study
Clinical Cancer Research, 11/17/09
Relevance Score: 83%
192R Allele of Paraoxanase 1 (PON1) Gene as a New Marker for Susceptibility to Bladder Cancer
Anticancer Research, 11/10/09
Relevance Score: 83%
Evidence-based Principles of Bladder Cancer and Diet
Urology, 10/21/09
Relevance Score: 83%
Biomarkers in bladder cancer
BJU International, 10/01/09
Relevance Score: 83%
Today in Bladder...keeping you current
Receive free subspecialty "5-minute updates" via email
A MicroRNA expression profile defining the invasive bladder tumor phenotype
Urologic Oncology: Seminars and Original Investigations, 12/18/09
Combination of vesicoureteric reflux and vesicoureteric junction obstruction
Scandinavian Journal of Urology and Nephrology, 12/18/09
Behavioral Intervention versus Pharmacotherapy or Their Combinations in the Management of Overactive Bladder Dysfunction
Advances in Urology, 12/18/09
Today in Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
High DNA Methyltransferase 3B Expression Mediates 5-Aza-Deoxycytidine Hypersensitivity in Testicular Germ Cell Tumors
Cancer Research, 12/18/09
Phase I trial with a combination of docetaxel and 153Sm-lexidronam in patients with castration-resistant metastatic prostate cancer
Urologic Oncology: Seminars and Original Investigations, 12/18/09
Prediction of Survival following First-Line Chemotherapy in Men with Castration-Resistant Metastatic Prostate Cancer
Clinical Cancer Research, 12/18/09